A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
NCT ID: NCT00502840
Last Updated: 2017-08-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
193 participants
INTERVENTIONAL
2007-07-23
2011-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.
NCT00424502
A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.
NCT00503425
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.
NCT00504777
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT01000610
A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies
NCT02097745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
rituximab [MabThera/Rituxan]
1g iv on days 1 and 15
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rituximab [MabThera/Rituxan]
1g iv on days 1 and 15
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* eligible for re-treatment (DAS28 \>2.6 after week 24, swollen joint count \>=4, tender joint count \>=4).
Exclusion Criteria
* patients with a previous response in DAS28 \<0.6 to MabThera after week 16;
* concurrent treatment with any DMARD except for methotrexate, any TNF alpha inhibitor, or other biologic or investigational agent.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rheumapraxis - Dres. Edmund Edelmann, Gerhard Straeßner und Hans Bloching
Bad Aibling, , Germany
Rheuma-Klinikum Bad Bramstedt Klinik fuer Rheumatologie und Immunologie
Bad Bramstedt, , Germany
Campus Charité Mitte Charité Centrum 12. Med.Klinik Abt.Rheumatologie u.Klin.Immunologie
Berlin, , Germany
Praxis Dr. Silke Zinke
Berlin, , Germany
Immanuel-Krankenhaus; Rheumklinik Berlin Buch
Berlin, , Germany
Ev. Waldkrankenhaus Spandau; Klinik für Innere Medizin
Berlin, , Germany
Ambulantes Rheumazentrum Dr.med. Helmut Sörensen
Berlin, , Germany
Universitätsklinikum Bonn Med. Klinik u.Poliklinik III
Bonn, , Germany
Klinik der Uni zu Köln; Klinik für Innere Medizin
Cologne, , Germany
HELIOS Seehospital Sahlenburg Abt.Internist.Rheumatologie
Cuxhaven, , Germany
Praxis PD Dr. med. Ekkehard Röther
Donaueschingen, , Germany
Rheumatologisches MVZ Dresden GmbH, Dres. Holger Schwenke, Reiner Schwenke, Annekatrin Georgi
Dresden, , Germany
Med. Versorgungszentrum Kästner + Kästner GbR Ambulantes Rheumazentrum
Erfurt, , Germany
Universitätsklinikum Erlangen; Medizinische Klinik 3; Rheumatologie und Immunologie
Erlangen, , Germany
Kliniken Essen; Süd Kath.Krankenhaus St.Josef; Abt. Rheumatologie und Immunologie
Essen, , Germany
Klinik Johann Wolfgang von Goethe Uni; Medizinische Klinik II; Abt. Rheumatologie
Frankfurt am Main, , Germany
Universitätsklinikum Freiburg; Medizinische UNI-Klinik; Abt. Innere Medizin - VI Rheumatologie
Freiburg im Breisgau, , Germany
Herz-Jesu-Krankenhaus Abt.Geriatrie u. Rheumatologie
Fulda, , Germany
Universitätsklinikum Gießen und Marburg GmbH Standort Gießen Medizinische Klinik III
Giessen, , Germany
MEDIGREIF Fachkrankenhaus fuer Rheumatologie und Orthopädie; Vogelsang-Gommern
Gommern, , Germany
Evangelisches Krankenhaus Hagen-Haspe Rheumaklinik
Hagen, , Germany
Universitätsklinikum Halle Klinik u.Poliklinik f.Innere Medizin I
Halle, , Germany
Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie
Hamburg, , Germany
Medizinische Hochschule Zentrum Innere Medizin Abt.Klinische Immunologie und Rheumatologie
Hanover, , Germany
Rheumapraxis PD Dr.med. Bernhard Heilig
Heidelberg, , Germany
UNI-Klinikum Heidelberg Medizinische Klinik Innere Medizin V
Heidelberg, , Germany
Rheumazentrum-Ruhrgebiet, St. Josefs-Krankenhaus; Rheumatologie
Herne, , Germany
Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
Homburg/Saar, , Germany
Universitätsklinikum Jena; Klinik für Innere Medizin III
Jena, , Germany
Praxis Dr.med. Ursula Mauß-Etzler
Karlsruhe, , Germany
Klinikum der Stadt Ludwigshafen; Medizinische Klinik A
Ludwigshafen, , Germany
Praxis Andreas Reck
Mittelherwigsdorf, , Germany
LMU München, Bereich Pettenkoferstr., Medizinische Poliklinik
München, , Germany
Praxis Prof. Dr.med. Herbert Kellner
München, , Germany
Gemeinschaftspraxis Prof. Dr. med. Klaus Krueger, Guenter Kellerer und Paul Kellerer
München, , Germany
Universitätsklinikum Münster Innere Medizin B
Münster, , Germany
Praxis Dr.med. Sylvia Berger
Naunhof, , Germany
Evang.Krankenhaus Medizinische Klinik
Oldenburg, , Germany
Rheumapraxis an der Hase
Osnabrück, , Germany
Praxis Dr.med. Anett Gräßler
Pirna, , Germany
Evangelisches Fachkrankenhaus; Rheumaklinik
Ratingen, , Germany
Klinikum der Uni Regensburg; Klinik f.Innere Medizin I Abt. Hämatologie und Internistische Onkologie
Regensburg, , Germany
Praxis Dr.med. Matthias Richter
Rostock, , Germany
St.-Josef-Stift Klinik für Rheumatologie
Sendenhorst, , Germany
Rheumatologische Schwerpunktpraxis am Feuersee
Stuttgart, , Germany
Johanniter-Krankenhaus im Fläming Treuenbrietzen GmbH; Fachklinik Pneumologie/ Thoraxchirurgie
Treuenbrietzen, , Germany
Universitätsklinikum Tübingen Medizinische UNI-Klinik und Poliklinik Abt. Innere Medizin II
Tübingen, , Germany
Universitätsklinikum Ulm; Medizinische Uni-Klinik III Abt. Innere Medizin III Hämatologie u. Onkolo.
Ulm, , Germany
Praxis Dr.med. Wolf-Dieter Wörth
Wiesbaden, , Germany
Medizinisches Zentrum Betriebsteil Marienhöhe Klinik f.Internistische Rheumatologie
Würselen, , Germany
Universitätsklinikum Würzburg; Medizinische Klinik und Poliklinik II; Hämatologie / Onkologie
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dimanche A, Bervini D, Miller DR, Schar A, Goldberg J, Raabe A, Dunn AK. Cortical perfusion measurements with laser speckle contrast imaging during adenosine induced cardiac arrest for aneurysm clipping: a case report. Acta Neurochir (Wien). 2024 Jan 23;166(1):27. doi: 10.1007/s00701-024-05925-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML19071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.